Monika Szczepanowski Selected Research

Monika Szczepanowski Research Topics

Disease

16	Lymphoma (Lymphomas) 01/2022 - 06/2006
10	B-Cell Lymphoma (Lymphoma, B Cell) 11/2017 - 06/2006
8	Neoplasms (Cancer) 01/2022 - 12/2009
6	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 09/2015
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 08/2013
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 08/2010
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2020 - 07/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 08/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2015 - 08/2010
2	Hodgkin Disease (Hodgkin's Disease) 07/2013 - 10/2007
2	Genetic Translocation (Chromosomal Translocation) 07/2011 - 08/2010
1	Lymphoid Leukemia 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Residual Neoplasm 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2020
1	Leiomyosarcoma 12/2020
1	Inflammation (Inflammations) 10/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2012
1	Microsatellite Instability 10/2012
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2011
1	Disease Progression 02/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2010
1	Lymphadenitis (Adenitis) 12/2009
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2007

Drug/Important Bio-Agent (IBA)

7	ParaffinIBA 12/2020 - 02/2013
7	Formaldehyde (Formol)FDA Link 12/2020 - 02/2013
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2006
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2007
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 07/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2013
2	carboxyl radical (COO-)IBA 12/2020 - 08/2017
2	CytokinesIBA 01/2020 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 07/2016 - 10/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2020
1	AntigensIBA 01/2020
1	cathepsin SIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	AutoantigensIBA 12/2018
1	EpitopesIBA 12/2018
1	neurabinIBA 12/2018
1	ExotoxinsIBA 12/2018
1	ChemokinesIBA 10/2018
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 08/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2017
1	human MIRN142 microRNAIBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	MicroRNAs (MicroRNA)IBA 11/2016
1	human MIRN376C microRNAIBA 11/2016
1	Phosphates (Orthophosphate)IBA 11/2015
1	hydrogen sulfite (bisulfite)IBA 11/2015
1	SphingosineIBA 11/2015
1	Long Noncoding RNAIBA 09/2015
1	Transcription Factors (Transcription Factor)IBA 09/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015
1	Rituximab (Mabthera)FDA Link 09/2015
1	Carrier Proteins (Binding Protein)IBA 09/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	Prednisone (Sone)FDA LinkGeneric 09/2015
1	Vincristine (Oncovin)FDA LinkGeneric 09/2015
1	Cyclin D1IBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2010
1	oncofetal fibronectinIBA 12/2009
1	TenascinIBA 12/2009
1	Protein Isoforms (Isoforms)IBA 12/2009
1	Coloring Agents (Dyes)IBA 12/2009
1	AntibodiesIBA 12/2009
1	Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA 10/2007

Therapy/Procedure

3	Therapeutics 10/2022 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2011
1	Precision Medicine 01/2022
1	Aftercare (After-Treatment) 01/2019
1	Ligation 06/2015
1	Lasers (Laser) 07/2013